Table 1.
Healthy Subjects | |||
All (n = 574) | Females (n = 319) | Males (n = 255) | |
Age | 41.4 ± 15.2 | 39.9 ± 15.2 * | 43.2 ± 15.2 |
Height (cm) | 172.8 ± 8.5 | 167.8 ± 6.5 * | 179.0 ± 6.3 |
Weight (kg) | 82.2 ± 18.7 | 78.1 ± 19.8 * | 87.3 ± 15.8 |
BMI (kg/m2) | 27.4 ± 5.6 | 27.6 ± 6.2 | 27.2 ± 4.5 |
Lean massDXA (kg) 1 | 54.6 ± 11.9 | 46.6 ± 7.6 * | 64.6 ± 8.2 |
Muscle massMRI (kg) | 26.1 ± 6.8 | 21.4 ± 3.8 * | 31.7 ± 5.1 |
ASMIDXA (kg/m2) | 8.2 ± 1.6 | 7.4 ± 1.2 * | 9.3 ± 1.3 |
FMIDXA (kg/m2) | 8.0 ± 15.2 | 9.8 ± 4.2 * | 9.3 ± 1.3 |
Non Sarcopenic | 81.0% | 80.9% | 81.2% |
Sarcopenic | 19.0% | 19.1% | 18.8% |
Cirrhotic Patients | |||
All (n = 403) | Females (n = 193) | Males (n = 210) | |
Age | 44.7 ± 12.3 | 44.5 ± 12.9 | 44.9 ± 11.8 |
Height (cm) | 170.5 ± 9.1 | 164.6 ± 6.7 * | 175.9 ± 7.5 |
Body Weight (kg) | 67.5 ± 14.3 | 59.9 ± 11.0 * | 74.4 ± 13.5 |
BMI (kg/m2) | 23.1 ± 3.9 | 22.1 ± 3.6 * | 24.0 ± 3.9 |
Lean massbia (kg) 1 | 50.7 ± 10.5 | 43.1 ± 5.6 * | 57.7 ± 9.1 |
Total body proteinTBK (kg) | 7.5 ± 2.3 | 6.5 ± 1.5 * | 8.8 ± 2.4 |
FFMIBIA (kg/m2) | 17.3 ± 2.4 | 15.9 ± 1.6 * | 18.6 ± 2.3 |
FMIBIA (kg/m2) | 5.8 ± 2.7 | 6.2 ± 2.8 * | 5.4 ± 2.5 |
Non Sarcopenic | 70.7% | 69.4% | 71.9% |
Sarcopenic | 29.3% | 30.6% | 28.1% |
Cancer Patients | |||
All (n = 547) | Females (n = 157) | Males (n = 390) | |
Age | 61.3 ± 8.2 | 62.8 ± 7.8 * | 60.8 ± 8.4 |
Height (cm) | 168.7 ± 9.6 | 158.4 ± 6.8 * | 172.8 ± 7.1 |
Weight (kg) | 70.8 ± 14.0 | 63.6 ± 11.4 * | 73.7 ± 13.9 |
BMI (kg/m2) | 24.8 ± 3.9 | 25.3 ± 4.1 * | 24.6 ± 3.8 |
Lean massCT (kg) 1 | 48.6 ± 9.6 | 38.2 ± 4.9 | 52.8 ± 7.7 |
ASMICT (kg/m2) | 6.6 ± 1.0 | 5.9 ± 0.8 * | 6.9 ± 0.9 |
FMICT (kg/m2) 2 | 7.9 ± 2.3 | 9.2 ± 2.4 * | 7.3 ± 2.1 |
Non Sarcopenic | 53.4% | 77.1% | 43.8% |
Sarcopenic | 46.6% | 22.9% | 56.2% |
Data are presented as means ± SD or percent; * significant differences between females and males (t-test): p < 0.05; ASMI = appendicular skeletal muscle mass index; BMI = body mass index; FFMI = fat free mass index; FMI = fat mass index; BIA = Bioelectrical Impedance Analysis; DXA = Dual-energy X-ray absorptiometry; MRI = Magnetic resonance imaging; TBK = Total body potassium; CT = Computer tomography; 1 Lean mass = Lean soft tissueDXA in healthy subjects; Fat free massBIA in cirrhotic patients and Lean soft tissueCT in cancer patients; 2 n = 531 total; 153 females; 378 males.